Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Other Non-Current Assets (2016 - 2026)

Champions Oncology has reported Other Non-Current Assets over the past 16 years, most recently at $196000.0 for Q1 2026.

  • Quarterly results put Other Non-Current Assets at $196000.0 for Q1 2026, up 5.95% from a year ago — trailing twelve months through Jan 2026 was $196000.0 (up 5.95% YoY), and the annual figure for FY2025 was $196000.0, up 5.95%.
  • Other Non-Current Assets for Q1 2026 was $196000.0 at Champions Oncology, roughly flat from $196000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for CSBR hit a ceiling of $196000.0 in Q2 2025 and a floor of $15000.0 in Q1 2022.
  • Median Other Non-Current Assets over the past 5 years was $185000.0 (2023), compared with a mean of $127529.4.
  • Biggest five-year swings in Other Non-Current Assets: tumbled 82.56% in 2022 and later soared 1133.33% in 2023.
  • Champions Oncology's Other Non-Current Assets stood at $15000.0 in 2022, then soared by 1133.33% to $185000.0 in 2023, then changed by 0.0% to $185000.0 in 2024, then grew by 5.95% to $196000.0 in 2025, then changed by 0.0% to $196000.0 in 2026.
  • The last three reported values for Other Non-Current Assets were $196000.0 (Q1 2026), $196000.0 (Q4 2025), and $196000.0 (Q3 2025) per Business Quant data.